Hua Qu Selected Research

coenzyme Q10 (CoQ10)

11/2018	The effect of statin treatment on circulating coenzyme Q10 concentrations: an updated meta-analysis of randomized controlled trials.
10/2018	Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua Qu Research Topics

Disease

16	Insulin Resistance 09/2021 - 01/2013
13	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2013
12	Inflammation (Inflammations) 02/2024 - 01/2013
7	Myocardial Infarction 03/2024 - 04/2016
7	Atherosclerosis 01/2024 - 01/2005
6	Obesity 09/2021 - 01/2013
5	Hypertension (High Blood Pressure) 01/2024 - 01/2022
5	Chronic Renal Insufficiency 02/2023 - 01/2020
4	Diabetic Cardiomyopathies 01/2023 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2018
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2005
4	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2014
4	Neoplasms (Cancer) 08/2021 - 06/2019
3	Fibrosis (Cirrhosis) 03/2024 - 01/2017
3	Heart Failure 02/2024 - 01/2022
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 11/2016
3	Stroke (Strokes) 01/2022 - 10/2008
3	Necrosis 01/2021 - 04/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2018
3	Glucose Intolerance 09/2018 - 01/2015
2	Pathologic Processes 03/2024 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 01/2022
2	Overweight 01/2024 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022 - 01/2022
2	Erectile Dysfunction 10/2022 - 10/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 11/2021
2	Obstructive Sleep Apnea 01/2022 - 01/2018
2	Infarction (Infarctions) 01/2022 - 10/2008
2	Hypotension (Low Blood Pressure) 09/2021 - 01/2021
2	Hyperkalemia 09/2021 - 01/2021
2	Prediabetic State (Prediabetes) 09/2021 - 01/2016
2	Hyperglycemia 01/2019 - 11/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2017
1	Kidney Diseases (Kidney Disease) 12/2023
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2023
1	Thrombosis (Thrombus) 05/2023
1	Vascular Diseases (Vascular Disease) 05/2023
1	Snoring 12/2022
1	Abdominal Obesity 12/2022

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2015
8	Insulin (Novolin)FDA Link 01/2024 - 05/2015
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
7	Triglycerides (Triacylglycerol)IBA 01/2022 - 05/2015
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2014
5	LipidsIBA 01/2024 - 01/2016
4	AlbuminsIBA 09/2021 - 11/2016
4	Hypoglycemic Agents (Hypoglycemics)IBA 03/2021 - 11/2017
3	Capsules (Microcapsules)IBA 01/2023 - 04/2018
3	CholesterolIBA 12/2022 - 01/2016
3	SaponinsIBA 02/2021 - 01/2018
3	C-Reactive ProteinIBA 01/2021 - 01/2016
3	HDL CholesterolIBA 09/2018 - 05/2015
2	trimethyloxamine (trimethylamine N-oxide)IBA 02/2024 - 05/2023
2	Valsartan (Vals)FDA Link 01/2024 - 01/2023
2	BerberineIBA 05/2023 - 04/2016
2	EnzymesIBA 05/2023 - 07/2015
2	Testosterone (Sustanon)FDA Link 12/2022 - 01/2022
2	Phosphodiesterase 5 InhibitorsIBA 10/2022 - 10/2022
2	AntioxidantsIBA 10/2022 - 10/2022
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2022 - 10/2022
2	PotassiumIBA 07/2022 - 09/2021
2	astragaloside AIBA 03/2022 - 11/2021
2	oxidized low density lipoproteinIBA 01/2022 - 01/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2021 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2021
2	tetramethylpyrazineIBA 11/2020 - 04/2016
2	Cardiotonic Agents (Cardiac Stimulants)IBA 04/2020 - 06/2019
2	BufanolidesIBA 04/2020 - 06/2019
2	Anesthetics (Anesthetic Agents)IBA 04/2020 - 06/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 10/2018
2	coenzyme Q10 (CoQ10)IBA 11/2018 - 10/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2018 - 01/2016
2	AdipokinesIBA 01/2018 - 05/2015
2	CateninsIBA 11/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 09/2017 - 10/2016
2	CytokinesIBA 02/2017 - 01/2014
2	Alanine Transaminase (SGPT)IBA 10/2016 - 01/2016
2	ORALIT (ORS)IBA 01/2016 - 01/2014
1	Contrast MediaIBA 03/2024
1	CollagenIBA 03/2024
1	IronIBA 03/2024
1	Volatile Fatty AcidsIBA 02/2024
1	TabletsIBA 01/2024
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2023
1	Liver X ReceptorsIBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	Choline (Choline Chloride)IBA 05/2023
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 02/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2023
1	Annexin A2 (Annexin II)IBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022
1	Proprotein Convertase 9IBA 10/2022
1	Uremic ToxinsIBA 01/2022
1	IndicanIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Capsaicin (Zostrix)FDA Link 01/2022

Therapy/Procedure

13	Therapeutics 03/2024 - 01/2012
2	Percutaneous Coronary Intervention 01/2021 - 01/2018